Inhalation Sciences signs IRS contract worth 584,000 SEK with leading nanotech company Kumar Jeetendra | February 18, 2022 Inhalation Research Services, ISAB’s contract research organization, has signed a contract worth 584 000 SEK with a leading nanotechnology company that specializes in developing new inhalable nanoporous particles for drug delivery. The client has chosen ISAB’s unique intratracheal in vivo exposure module for its research project, due to its proven precision and reliability. The development …
Inhalation Research Services chosen for new research project worth 1.45 million SEK by US pharma company Kumar Jeetendra | July 18, 2022 (Stockholm 18 July 2022) A US company with an extensive pipeline in medical dermatology has chosen Inhalation Research Services (IRS), ISAB’s contract research organization, for a research project worth 1.45 million SEK (1.36 K Euro) into a new repurposed drug that is being reformulated for administration via the lungs. ISAB’s world-class expertise in inhalation, and …
